CRISPR Therapeutics AG (CRSP) Intangibles (2015 - 2024)
CRISPR Therapeutics AG (CRSP) posted Intangibles of $2000.0 for Q1 2024, down 87.5% sequentially from $16000.0 in Q4 2023, and down 96.49% YoY from $57000.0 in Q2 2023.
CRISPR Therapeutics AG (CRSP) Intangibles (2015 - 2024) Analysis & Trends
CRISPR Therapeutics AG has reported Intangibles for 10 years, with the latest figure at $2000.0 in Q1 2024.
- Quarterly Intangibles fell 96.49% year-over-year to $2000.0 in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $2000.0 (down 96.49% YoY) and the FY2023 annual result came in at $16000.0, down 77.46% from the prior year.
- Intangibles fell to $2000.0 in Q1 2024 per CRSP's latest filing, from $16000.0 in the prior quarter.
- Over five years, Intangibles peaked at $221000.0 in Q1 2020 and troughed at $2000.0 in Q1 2024.
- A 5-year average of $111764.7 and a median of $112000.0 in 2022 frame the typical range for Intangibles.
- The sharpest annual moves came in 2020 and 2024: Intangibles dropped 19.93% in 2020, then sank 96.49% in 2024.
- Over 5 years, Intangibles stood at $180000.0 in 2020, then slumped by 30.56% to $125000.0 in 2021, then tumbled by 43.2% to $71000.0 in 2022, then slumped by 77.46% to $16000.0 in 2023, then tumbled by 87.5% to $2000.0 in 2024.
- According to Business Quant data, Intangibles over the past three periods registered $2000.0, $16000.0, and $30000.0 for Q1 2024, Q4 2023, and Q3 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 412.80 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 266.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 63.28 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 60.96 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 93.49 Mn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 30,000.00 |
| Jun 30, 2023 | 43,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 71,000.00 |
| Sep 30, 2022 | 84,000.00 |
| Jun 30, 2022 | 98,000.00 |
| Mar 31, 2022 | 112,000.00 |
| Dec 31, 2021 | 125,000.00 |
| Sep 30, 2021 | 139,000.00 |
| Jun 30, 2021 | 153,000.00 |
| Mar 31, 2021 | 167,000.00 |
| Dec 31, 2020 | 180,000.00 |
| Sep 30, 2020 | 194,000.00 |
| Jun 30, 2020 | 208,000.00 |
| Mar 31, 2020 | 221,000.00 |
| Dec 31, 2019 | 235,000.00 |
| Sep 30, 2019 | 249,000.00 |
| Jun 30, 2019 | 262,000.00 |